Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7692) 7692
Newspaper Article (97) 97
Magazine Article (59) 59
Book Chapter (17) 17
Book / eBook (10) 10
Newsletter (5) 5
Conference Proceeding (4) 4
Web Resource (2) 2
Dissertation (1) 1
Government Document (1) 1
Publication (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5494) 5494
science & technology (4988) 4988
life sciences & biomedicine (4703) 4703
chelating agents - therapeutic use (3020) 3020
male (2626) 2626
animals (2531) 2531
female (2233) 2233
iron chelating agents - therapeutic use (1839) 1839
biological and medical sciences (1610) 1610
medical sciences (1458) 1458
adult (1350) 1350
chelating agents (1142) 1142
chelating agents - pharmacology (934) 934
middle aged (918) 918
pharmacology & pharmacy (891) 891
rats (836) 836
mice (829) 829
iron (777) 777
child (767) 767
iron - metabolism (763) 763
adolescent (721) 721
deferoxamine - therapeutic use (718) 718
treatment outcome (707) 707
hematology (697) 697
chelation therapy (676) 676
chelating agents - chemistry (597) 597
biochemistry & molecular biology (593) 593
toxicology (591) 591
abridged index medicus (590) 590
iron overload - drug therapy (588) 588
iron chelating agents - pharmacology (565) 565
pharmacology. drug treatments (549) 549
aged (545) 545
chelation (532) 532
edetic acid - therapeutic use (506) 506
chemistry (459) 459
pyridones - therapeutic use (455) 455
child, preschool (449) 449
time factors (433) 433
oncology (395) 395
health aspects (382) 382
analysis (381) 381
care and treatment (381) 381
physical sciences (380) 380
iron overload - etiology (379) 379
ferritins - blood (377) 377
urology & nephrology (372) 372
iron overload (365) 365
chelating agents - administration & dosage (362) 362
benzoates - therapeutic use (361) 361
neurosciences & neurology (360) 360
triazoles - therapeutic use (359) 359
oxidative stress (350) 350
penicillamine - therapeutic use (340) 340
lead poisoning - drug therapy (337) 337
transfusion reaction (335) 335
general & internal medicine (334) 334
iron chelating agents - administration & dosage (329) 329
deferiprone (327) 327
blood transfusion (324) 324
beta-thalassemia - drug therapy (315) 315
liver - metabolism (313) 313
medicine, general & internal (311) 311
research (311) 311
iron chelating agents - adverse effects (309) 309
neurosciences (304) 304
young adult (304) 304
antioxidants (295) 295
thalassemia (295) 295
administration, oral (294) 294
deferoxamine (293) 293
copper (291) 291
chelating agents - adverse effects (284) 284
dose-response relationship, drug (284) 284
proteins (281) 281
disease models, animal (277) 277
magnetic resonance imaging (271) 271
deferasirox (270) 270
drug therapy, combination (267) 267
metals (263) 263
hepatolenticular degeneration - drug therapy (259) 259
toxicity (255) 255
cell line, tumor (254) 254
medicine & public health (253) 253
chemical and industrial products toxicology. toxic occupational diseases (249) 249
risk factors (245) 245
tissue distribution (243) 243
copper - metabolism (239) 239
cancer (238) 238
metals and various inorganic compounds (237) 237
cell biology (236) 236
research article (235) 235
pediatrics (234) 234
sevelamer (231) 231
succimer - therapeutic use (231) 231
dentistry (229) 229
beta-thalassemia - complications (224) 224
rats, wistar (223) 223
beta-thalassemia - therapy (219) 219
chemistry, medicinal (218) 218
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7357) 7357
French (158) 158
German (110) 110
Russian (103) 103
Japanese (68) 68
Spanish (61) 61
Italian (57) 57
Polish (30) 30
Dutch (27) 27
Chinese (24) 24
Portuguese (24) 24
Czech (12) 12
Romanian (8) 8
Danish (5) 5
Hebrew (5) 5
Hungarian (4) 4
Norwegian (3) 3
Turkish (3) 3
Bulgarian (2) 2
Croatian (2) 2
Lithuanian (2) 2
Slovak (2) 2
Finnish (1) 1
Persian (1) 1
Serbian (1) 1
Slovenian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


81. Full Text Iron Chelators with Topoisomerase-Inhibitory Activity and Their Anticancer Applications
by Rao, V. Ashutosh
Antioxidants & redox signaling, ISSN 1523-0864, 03/2013, Volume 18, Issue 8, pp. 93 - 955
Forum Review Articles | Biochemistry & Molecular Biology | Endocrinology & Metabolism | Life Sciences & Biomedicine | Science & Technology | Neoplasms - metabolism | Iron Chelating Agents - therapeutic use | Humans | Antineoplastic Agents - therapeutic use | Cardiotonic Agents - chemistry | DNA Topoisomerases - metabolism | Cardiotonic Agents - pharmacology | Iron - adverse effects | Antineoplastic Agents - chemistry | Iron - metabolism | Iron Chelating Agents - chemistry | Neoplasms - drug therapy | Topoisomerase Inhibitors - therapeutic use | Iron Chelating Agents - pharmacology | Topoisomerase Inhibitors - chemistry | Antimitotic agents | Topoisomerases | Chelating agents | Research | Antineoplastic agents | Index Medicus | Forum Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
82. The multifactorial nature of Alzheimer's disease for developing potential therapeutics
by Carmo Carreiras, M and Mendes, Eduarda and Jesus Perry, M and Francisco, Ana Paula and Marco-Contelles, J
Current topics in medicinal chemistry, ISSN 1568-0266, 2013, Volume 13, Issue 15, pp. 1745 - 1770
Oxidative stress | ChEs | Dual AChE/BuChE inhibitors | dishomeostasis | MAO | Alzheimer's disease | Metal chelators | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Flocculation - drug effects | Neurons - pathology | Alzheimer Disease - physiopathology | Oxidative Stress | Apoptosis - drug effects | Calcium - metabolism | Humans | Alzheimer Disease - drug therapy | Enzyme Inhibitors - chemical synthesis | Enzyme Inhibitors - therapeutic use | Iron - metabolism | Amyloid Precursor Protein Secretases - metabolism | Amyloid beta-Peptides - antagonists & inhibitors | Alzheimer Disease - metabolism | Amyloid beta-Peptides - metabolism | Drug Design | Neurons - metabolism | Amyloid Precursor Protein Secretases - antagonists & inhibitors | Amyloid beta-Peptides - chemistry | Cholinesterases - metabolism | Chelating Agents - chemical synthesis | Neurons - drug effects | Chelating Agents - therapeutic use
Journal Article
Details down arrow
83. Full Text Use of phosphate-binding agents is associated with a lower risk of mortality
by Cannata-Andía, Jorge B and Fernández-Martín, José L and Locatelli, Francesco and London, Gérard and Gorriz, José L and Floege, Jürgen and Ketteler, Markus and Ferreira, Aníbal and Covic, Adrian and Rutkowski, Boleslaw and Memmos, Dimitrios and Bos, Willem-Jan and Teplan, Vladimir and Nagy, Judit and Tielemans, Christian and Verbeelen, Dierik and Goldsmith, David and Kramar, Reinhard and Martin, Pierre-Yves and Wüthrich, Rudolf P and Pavlovic, Drasko and Benedik, Miha and Sánchez, José Emilio and Martínez-Camblor, Pablo and Naves-Díaz, Manuel and Carrero, Juan J and Zoccali, Carmine
Kidney international, ISSN 0085-2538, 11/2013, Volume 84, Issue 5, pp. 998 - 1008
dialysis | phosphate binders | mineral metabolism | hyperparathyroidism | hyperphosphatemia | mortality risk | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Multivariate Analysis | Prospective Studies | Hyperphosphatemia - mortality | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Hyperphosphatemia - blood | Renal Insufficiency, Chronic - therapy | Renal Dialysis - mortality | Time Factors | Aged, 80 and over | Cardiovascular Diseases - mortality | Phosphates - blood | Renal Insufficiency, Chronic - mortality | Female | Renal Insufficiency, Chronic - diagnosis | Chelating Agents - therapeutic use | Cardiovascular Diseases - diagnosis | Risk Factors | Proportional Hazards Models | Europe - epidemiology | Treatment Outcome | Biomarkers - blood | Chi-Square Distribution | Renal Insufficiency, Chronic - blood | Propensity Score | Renal Dialysis - adverse effects | Hyperphosphatemia - drug therapy | Aged | Hyperphosphatemia - diagnosis | Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
84. Full Text Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: Efficacy and safety during 5 years' follow-up
by Cappellini, M. Domenica and Bejaoui, Mohamed and Agaoglu, Leyla and Canatan, Duran and Capra, Marcello and Cohen, Alan and Drelichman, Guillermo and Economou, Marina and Fattoum, Slaheddine and Kattamis, Antonis and Kilinc, Yurdanur and Perrotta, Silverio and Piga, Antonio and Porter, John B and Griffel, Louis and Dong, Victor and Clark, Joan and Aydinok, Yesim
Blood, ISSN 0006-4971, 07/2011, Volume 118, Issue 4, pp. 884 - 893
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Anemias. Hemoglobinopathies | Biological and medical sciences | Medical sciences | Diseases of red blood cells | Benzoates - adverse effects | Triazoles - administration & dosage | Triazoles - adverse effects | Benzoates - therapeutic use | Follow-Up Studies | Humans | Middle Aged | Child, Preschool | Deferoxamine - therapeutic use | Male | Growth and Development - drug effects | Young Adult | Adult | Female | Iron Chelating Agents - administration & dosage | Child | Chelation Therapy - methods | Triazoles - therapeutic use | Iron Chelating Agents - therapeutic use | Chelation Therapy - adverse effects | Iron - metabolism | Benzoates - administration & dosage | Iron Chelating Agents - adverse effects | Cross-Over Studies | Deferasirox | beta-Thalassemia - drug therapy | Adolescent | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
85. Full Text Nanoparticle–chelator conjugates as inhibitors of amyloid-β aggregation and neurotoxicity: A novel therapeutic approach for Alzheimer disease
by Liu, Gang and Men, Ping and Kudo, Wataru and Perry, George and Smith, Mark A
Neuroscience letters, ISSN 0304-3940, 2009, Volume 455, Issue 3, pp. 187 - 190
Drug-delivery | Chelator | Amyloid | Alzheimer disease | Nanoparticle | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Fundamental and applied biological sciences. Psychology | Vertebrates: nervous system and sense organs | Neurology | Biological and medical sciences | Medical sciences | Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases | Nanoparticles - chemistry | Humans | Iron Metabolism Disorders - complications | Nerve Degeneration - physiopathology | Plaque, Amyloid - drug effects | Nerve Degeneration - metabolism | Brain - metabolism | Nanoparticles - therapeutic use | Amyloid beta-Peptides - metabolism | Neurons - metabolism | Neurons - drug effects | Alzheimer Disease - physiopathology | Iron Chelating Agents - therapeutic use | Iron - antagonists & inhibitors | Brain - physiopathology | Iron Metabolism Disorders - drug therapy | Cells, Cultured | Alzheimer Disease - drug therapy | Iron - metabolism | Brain - drug effects | Amyloid beta-Peptides - antagonists & inhibitors | Iron Chelating Agents - pharmacology | Alzheimer Disease - metabolism | Iron Metabolism Disorders - metabolism | Neurotoxins - metabolism | Plaque, Amyloid - metabolism | Pyridones - therapeutic use | Neurotoxins - antagonists & inhibitors | Nerve Degeneration - drug therapy | Pyridones - pharmacology | Index Medicus | drug-delivery | nanoparticle | amyloid | chelator
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights